Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
74 hedge funds and large institutions have $36.8M invested in Genesis Healthcare, Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 8 closing their positions.
87% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 15
4% less funds holding
Funds holding: 77 → 74 (-3)
13% less capital invested
Capital invested by funds: $42.4M → $36.8M (-$5.59M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$505K |
| 2 |
VCM
V3 Capital Management
Dallas,
Texas
|
+$480K |
| 3 |
Renaissance Technologies
New York
|
+$286K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$284K |
| 5 |
FWC
First Washington Corp
Seattle,
Washington
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$2.77M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$296K |
| 3 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$268K |
| 4 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
-$145K |
| 5 |
JP Morgan Chase
New York
|
-$141K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAN
76
Claraphi Advisory Network
Aliso Viejo,
United States
| – | -$75K | -60,457 | Closed |
|
|
OAM
77
Oxford Asset Management
Oxford,
United Kingdom
| – | -$68K | -54,626 | Closed |
|
|
SRAM
78
Stone Ridge Asset Management
New York
| – | -$33K | -26,489 | Closed |
|
79
D.E. Shaw & Co
New York
| – | -$13K | -10,700 | Closed |
|
|
APA
80
American Portfolios Advisors
Holbrook,
New York
| – | -$267 | -215 | Closed |
|
GEN Hedge Fund Activity: Q3 2019 in Review
74 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2019, worth a combined $36.8M — down 13% from $42.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GEN and 5 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 28 added.
The largest buyer was Chevy Chase Trust, adding an estimated $505K. The largest seller was Columbia Pacific Advisors, exiting entirely with an estimated $2.77M sold.
- 74 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q3 2019, down from 77 in Q2 2019.
- Funds reported $36.8M of Genesis Healthcare, Inc. stock for Q3 2019, down 13% quarter-over-quarter.
- 5 funds opened new Genesis Healthcare, Inc. positions in Q3 2019 and 8 closed out, a net change of -3 holders.
- The largest Genesis Healthcare, Inc. buyer in Q3 2019 was Chevy Chase Trust, an estimated $505K added.
- The largest Genesis Healthcare, Inc. seller in Q3 2019 was Columbia Pacific Advisors, an estimated $2.77M sold.
Based on aggregated 13F filings for Q3 2019.